TitAIN Trial Provides Hope to Giant Cell Arteritis Patients
A recent phase 2 safety and efficacy study of an anti-interleukin-17A monoclonal antibody for the treatment of giant cell arteritis patients suggests there may soon be another alternative to ...
Steroid-toxicity in Children: Understudied, not Forgotten
Glucocorticoids remain a critical component of treating many pediatric diseases. According to Aulakh and Singh, in fact, it is estimated 10% of children may require some form of glucocorticoid during ...
A Clinician's Pearls and Myths in Rheumatology
“Despite the amazing advances in medicine since the first edition, so many patients with immune-mediated inflammatory disease remain soaked in steroids! Steroid-related toxicities continue to be a ...
In Conversation With… Deborah Gelinas, MD
“The damage caused by steroid exposure is not surprising - it is expected.” Deborah Gelinas, MD is a Neuromuscular Expert Medical Affairs for Argenx. She also serves as an Associate Professor in the ...
Steroid-toxicities rarely present alone
A new study published in Lancet Rheumatology [1] by an international team of clinical researchers has highlighted how pervasive and nuanced steroid-toxicity is and how important it is to have a ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
